3-38697226-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006514.4(SCN10A):c.*123C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 1,470,942 control chromosomes in the GnomAD database, including 147,134 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.44 ( 14628 hom., cov: 32)
Exomes 𝑓: 0.44 ( 132506 hom. )
Consequence
SCN10A
NM_006514.4 3_prime_UTR
NM_006514.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.649
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 3-38697226-G-A is Benign according to our data. Variant chr3-38697226-G-A is described in ClinVar as [Benign]. Clinvar id is 1259657.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.45 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN10A | ENST00000449082 | c.*123C>T | 3_prime_UTR_variant | Exon 28 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | |||
SCN10A | ENST00000655275 | c.*123C>T | 3_prime_UTR_variant | Exon 28 of 28 | ENSP00000499510.1 | |||||
SCN10A | ENST00000643924.1 | c.*123C>T | downstream_gene_variant | ENSP00000495595.1 |
Frequencies
GnomAD3 genomes AF: 0.437 AC: 66303AN: 151894Hom.: 14636 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
66303
AN:
151894
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.444 AC: 585843AN: 1318930Hom.: 132506 Cov.: 21 AF XY: 0.445 AC XY: 287556AN XY: 646802 show subpopulations
GnomAD4 exome
AF:
AC:
585843
AN:
1318930
Hom.:
Cov.:
21
AF XY:
AC XY:
287556
AN XY:
646802
Gnomad4 AFR exome
AF:
AC:
13585
AN:
29690
Gnomad4 AMR exome
AF:
AC:
11160
AN:
29742
Gnomad4 ASJ exome
AF:
AC:
8312
AN:
19942
Gnomad4 EAS exome
AF:
AC:
4919
AN:
38500
Gnomad4 SAS exome
AF:
AC:
29527
AN:
68062
Gnomad4 FIN exome
AF:
AC:
18491
AN:
39746
Gnomad4 NFE exome
AF:
AC:
474325
AN:
1034762
Gnomad4 Remaining exome
AF:
AC:
23758
AN:
54810
Heterozygous variant carriers
0
15831
31662
47493
63324
79155
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
14480
28960
43440
57920
72400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.436 AC: 66308AN: 152012Hom.: 14628 Cov.: 32 AF XY: 0.432 AC XY: 32106AN XY: 74296 show subpopulations
GnomAD4 genome
AF:
AC:
66308
AN:
152012
Hom.:
Cov.:
32
AF XY:
AC XY:
32106
AN XY:
74296
Gnomad4 AFR
AF:
AC:
0.448241
AN:
0.448241
Gnomad4 AMR
AF:
AC:
0.40212
AN:
0.40212
Gnomad4 ASJ
AF:
AC:
0.418638
AN:
0.418638
Gnomad4 EAS
AF:
AC:
0.137804
AN:
0.137804
Gnomad4 SAS
AF:
AC:
0.410982
AN:
0.410982
Gnomad4 FIN
AF:
AC:
0.477083
AN:
0.477083
Gnomad4 NFE
AF:
AC:
0.454136
AN:
0.454136
Gnomad4 OTH
AF:
AC:
0.451659
AN:
0.451659
Heterozygous variant carriers
0
1903
3806
5709
7612
9515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1036
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at